What is the equity of Genus this year?
Genus has equity of 574.9 M GBP this year.
In 2024, Genus's equity was 574.9 M GBP, a -0.62% increase from the 578.5 M GBP equity in the previous year.
Genus's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Genus's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating Genus's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Genus's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in Genus’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Genus has equity of 574.9 M GBP this year.
The equity of Genus has increased/decreased by -0.62% decreased compared to the previous year.
A high equity is advantageous for investors of Genus as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of Genus, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of Genus can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of Genus can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of Genus include profits, dividend payments, capital increases, and acquisitions.
The equity of Genus is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, Genus can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, Genus paid a dividend of 0.32 GBP . This corresponds to a dividend yield of about 1.77 %. For the coming 12 months, Genus is expected to pay a dividend of 0.33 GBP.
The current dividend yield of Genus is 1.77 %.
Genus pays a quarterly dividend. This is distributed in the months of December, April, December, March.
Genus paid dividends every year for the past 25 years.
For the upcoming 12 months, dividends amounting to 0.33 GBP are expected. This corresponds to a dividend yield of 1.83 %.
Genus is assigned to the 'Health' sector.
To receive the latest dividend of Genus from 3/28/2024 amounting to 0.103 GBP, you needed to have the stock in your portfolio before the ex-date on 2/29/2024.
The last dividend was paid out on 3/28/2024.
In the year 2023, Genus distributed 0.32 GBP as dividends.
The dividends of Genus are distributed in GBP.
The Genus stock can be added to a savings plan with the following providers: Trade Republic
Our stock analysis for Genus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.